(Q77554668)
Statements
Phase IB trial of chimeric antidisialoganglioside antibody plus interleukin 2 for melanoma patients (English)
Albertini MR
Hank JA
Schiller JH
Khorsand M
Borchert AA
Gan J
Bechhofer R
Storer B
Reisfeld RA